SuperUROP: Showcasing students' research work in progress
Undergraduate researchers discussed their projects at a well-attended poster session.
Scientists engineer new CRISPR platform for DNA targeting
CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox.
From microfluidics to metastasis
New platform enables longitudinal studies of circulating tumor cells in mouse models of cancer.
Mapping the brain at high resolution
New 3-D imaging technique can reveal, much more quickly than other methods, how neurons connect throughout the brain.
DNA design that anyone can do
Computer program can translate a free-form 2-D drawing into a DNA structure.
Three at MIT named 2018 fellows of the National Academy of Inventors
MIT president and two engineering faculty recognized for contributions with tangible impacts on quality of life, economic development, and the welfare of society.
Team invents method to shrink objects to the nanoscale
It’s not quite the Ant-Man suit, but the system produces 3-D structures one thousandth the size of the originals.
3Q: Eric Alm on the mysteries of the microbiome
“A diet or treatment of the microbiome may lead to increased diversity, but that does not mean it's better or healthier for you,” says the engineering professor.
MIT engineers repurpose wasp venom as an antibiotic drug
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.
Measuring cancer cell “fitness” reveals drug susceptibility
Together, cell growth rate and gene expression shed light on why some tumor cells survive treatment.
Potential arthritis treatment prevents cartilage breakdown
Injectable material made of nanoscale particles can deliver arthritis drugs throughout cartilage.
Sixteen grad students named to the Siebel Scholars class of 2019
MIT students from the fields of bioengineering, business, computer science, and energy science receive the prestigious awards.
Bridge to the future of engineering
The School of Engineering’s faculty leadership weigh in on what the MIT Stephen A. Schwarzman College of Computing will mean for their students and faculty.
Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
New CRISPR tool opens up more of the genome for editing
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.